AI assistant
XBiotech Inc. — Director's Dealing 2017
May 25, 2017
34229_dirs_2017-05-25_67da352a-fe33-4618-b41e-ce6362feeb6c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2017-05-24
Reporting Person: SIMARD JOHN (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-24 | Common Stock | M | 240000 | $0.9317 | Acquired | 6393267 | Direct |
| 2017-05-24 | Common Stock | F | 116207 | $8.17 | Disposed | 6277060 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-24 | Stock Option | $0.9317 | M | 240000 | Disposed | 2017-06-15 | Common Stock (240000) | Direct |
Footnotes
F1: Options granted on June 15, 2007 with a strike price of $1.25 CAD, which was converted to $0.9317 USD using an exchange rate of 0.7454.
F2: Due to the options expiring on June 15, 2017, Mr. Simard agreed to exercise these options through the "net exercise" method on May 24, 2017. Mr. Simard received 123,793 shares of common stock on a net exercise to purchase 240,000 shares of common stock. Mr. Simard forfeited 116,207 shares of common stock underlying the option in payment of the exercise price and associated taxes, using the closing stock price on May 24, 2017 of $8.17.